<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03040063</url>
  </required_header>
  <id_info>
    <org_study_id>EVAR-P</org_study_id>
    <nct_id>NCT03040063</nct_id>
  </id_info>
  <brief_title>Complex Endovascular Approach to Treatment of Patients With Aneurysm of Popliteal Artery</brief_title>
  <acronym>EVAR-P</acronym>
  <official_title>Complex Endovascular Approach to Treatment of Patients With Aneurysm of Popliteal Artery and Acute Limb Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Petr Varejka</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charles University, Czech Republic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of endovascular techniques - implantation of a peripheral stent graft and a peripheral&#xD;
      flexible stent to isolate the sac of the popliteal artery aneurysm from the circulation and&#xD;
      subsequent topical application of a thrombolytic (rtPA) to restore patency of the lower leg&#xD;
      blood stream - will lead to a comparable or better outcome in treatment of patients with the&#xD;
      popliteal artery aneurysm and acute critical limb ischaemia, compared to currently prevailing&#xD;
      use of surgical treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The 2nd Medical Department admits patients with acute arterial occlusion at the stage of&#xD;
      critical limb ischaemia. The poorest prognosis considering preservation of the limb is shown&#xD;
      by the patients who exhibit symptoms of ischaemia due to affected popliteal artery and&#xD;
      arteries of the shank in the the popliteal artery aneurysm. On the other hand, diagnosis of&#xD;
      this condition is prompt and easy (general ultrasound scan below the knee). Patients with the&#xD;
      popliteal artery aneurysm, confirmed by ultrasound investigation, and concurrent signs and&#xD;
      symptoms of acute critical ischaemia will be indicated for catheterization intervention at&#xD;
      our unit, which will confirm morphological compatibility with endovascular occlusion of the&#xD;
      aneurysm sac through implantation of a peripheral stent graft, supported by implantation of a&#xD;
      peripheral flexible stent, and at the same time insertion of a thrombolytic catheter into the&#xD;
      implanted stent graft for local thrombolysis of tibial arteries if required by the current&#xD;
      situation. The patient will be hospitalized at the angiology intensive care unit of the 2nd&#xD;
      Medical Department, where local intra-arterial thrombolytic therapy will be performed&#xD;
      according to the standard protocol. After completion of the proper endovascular treatment,&#xD;
      the patients will be transferred to combined peroral anticoagulation and antiaggregation&#xD;
      treatment, and all of them will have an ultrasound scan below the knee, with the readings&#xD;
      archived for the purpose of further comparison and monitoring. Subsequently, the patients&#xD;
      will be monitored in the outpatient regime after 6 weeks, 3, 6 and 12 months. At each visit,&#xD;
      clinical examination will be done including establishment of ABI/TBI values and ultrasound&#xD;
      investigation of the region below the knee.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Limb salvage in 12 months</measure>
    <time_frame>12 Months</time_frame>
    <description>Limba salvage in 12 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patency of the popliteal artery in 12 months</measure>
    <time_frame>12 Months</time_frame>
    <description>Patency of the popliteal artery in 12 months</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Aneurysm; Popliteal Artery</condition>
  <condition>Limb Ischemia</condition>
  <arm_group>
    <arm_group_label>Combined endovascular approach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combined endovascular approach using covered stent and flexible stent in the popliteal artery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard optimal therapy (OPT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>standard therapy of popliteal artery aneurysm using thrombolysis and surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combined endovascular approach (EVAR)</intervention_name>
    <description>puncture of SFA in orthograde position if possible&#xD;
DSA through 4F dilator, proof of occlusion&#xD;
wire test&#xD;
Heparin 70-80 IU/kg i.a.&#xD;
implantation of peripheral stent graft VIABAHN&#xD;
implantation of peripheral stent SUPERA into stent graft&#xD;
insertion of strait flush catheter for local thrombolysis&#xD;
administration of continuous local thrombolysis in the dose of 1 mg/hr., unfractionated heparin continuously (APTT 1,5-2x) according to the department standards&#xD;
control angiography in 12 hrs or earlier according to clinical status and symptoms&#xD;
repeated angiography in 24 hrs</description>
    <arm_group_label>Combined endovascular approach</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard optimal therapy (OPT)</intervention_name>
    <description>puncture of SFA in orthograde position if possible&#xD;
DSA through 4F dilator, proof of occlusion&#xD;
wire test&#xD;
Unfractionated heparin 70-80 IU/kg i.a.&#xD;
insertion of strait flush catheter for local thrombolysis&#xD;
administration of continuous local thrombolysis in the dose of 1 mg/hr., unfractionated heparin continuously (APTTT 1,5-2x)&#xD;
control angiography in 12 hrs or according to clinical status and symptoms&#xD;
repeated angiography in24 hrs&#xD;
Final result review, vascular team consultation and indication for surgical or conservative management of popliteal artery aneurysm.</description>
    <arm_group_label>Standard optimal therapy (OPT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Signed informed consent form for the patient's participation in the study.&#xD;
&#xD;
          2. Acute critical limb ischaemia with impairment of the extremity at stage I, IIa, IIb&#xD;
             according to SVS classification.&#xD;
&#xD;
          3. A popliteal artery aneurysm, confirmed by ultrasound scanning, which on&#xD;
             catheterization examination meets the criteria for isolation of the aneurysm sac by&#xD;
             implantation of a peripheral stent graft, supported by insertion of a peripheral&#xD;
             flexible stent.&#xD;
&#xD;
          4. Absence of any contraindication for local thrombolytic therapy.&#xD;
&#xD;
          5. An anatomic finding through angiographic investigation that is suitable for&#xD;
             endovascular therapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Active bleeding or contraindication for local thrombolysis.&#xD;
&#xD;
          2. Life expectance &lt; 1 yr&#xD;
&#xD;
          3. Relevant stenotic defects of valves.&#xD;
&#xD;
          4. Myocardial infarction or unstable angina pectoris in past 3 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean Claude Lubanda, Ass.Prof., MD., Ph.D.</last_name>
    <phone>00420224962692</phone>
    <email>Jean-Claude.Lubanda@vfn.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charles University in Prague</name>
      <address>
        <city>Prague</city>
        <zip>12808</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Claude Lubanda, Ass.Prof.MD</last_name>
      <phone>+420224962692</phone>
      <email>Jean-Claude.Lubanda@vfn.cz</email>
    </contact>
    <contact_backup>
      <last_name>Martina Striteska, Mgr.</last_name>
      <phone>+224962605</phone>
      <email>Martina.Striteska@vfn.cz</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Claude Lubanda, Ass.Prof.MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>January 31, 2017</study_first_submitted>
  <study_first_submitted_qc>January 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2017</study_first_posted>
  <last_update_submitted>January 31, 2017</last_update_submitted>
  <last_update_submitted_qc>January 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charles University, Czech Republic</investigator_affiliation>
    <investigator_full_name>Ass. prof. Jean-Claude M. Lubanda, MD, Ph.D</investigator_full_name>
    <investigator_title>Ass.prof. MD, Ph.D.</investigator_title>
  </responsible_party>
  <keyword>aneurysm, poplietl artery, acute limb ischemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

